Gene · 2182
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IDH1 and ATRX mutations synergistically modulate cell proliferation and ferroptosis in glioblastoma cells. | Am J Cancer Res | 2025 | 41523255 | PubTator, text mining | PubMed |
| Ferroptosis: Mechanisms, Comparison with Cuproptosis and Emerging Horizons in Therapeutics. | Oncol Res | 2025 | 41502519 | PubTator, text mining | PubMed |
| Novel protein acylations in ferroptosis: decoding the regulatory roles of lactylation, crotonylation, succinylation, and β-hydroxybutyrylation. | Front Pharmacol | 2025 | 41480383 | PubTator, text mining | PubMed |
| Ferroptosis in Hypertriglyceridemic Acute Pancreatitis: Mechanisms and Therapeutic Implications. | J Inflamm Res | 2025 | 41466855 | PubTator, text mining | PubMed |
| Gene Expression-Based Inference of Metabolic Signatures Reveals Distinct Molecular Profiles in Right- and Left-Sided Colon Cancer. | Metabolites | 2025 | 41441010 | PubTator, text mining | PubMed |
| SLC11A1 can activate TGF-β1 signaling pathway to resist ferroptosis in colorectal cancer. | Sci Rep | 2025 | 41436829 | PubTator, text mining | PubMed |
| Targeting ferroptosis: novel therapeutic approaches and intervention strategies for kidney diseases. | Front Immunol | 2025 | 41425591 | PubTator, text mining | PubMed |
| Multilayered genetic dissection of autism: insights from whole-exome sequencing, molecular karyotyping, and cytogenetic analyses in a small Turkish cohort. | Neurogenetics | 2025 | 41420732 | PubTator, text mining | PubMed |
| Nicotinamide riboside alleviates sepsis-induced acute kidney injury by suppressing ferroptosis. | J Mol Med (Berl) | 2025 | 41419644 | PubTator, text mining | PubMed |
| Nicotinamide Mononucleotide Alleviates the Development of Fibrotic Cataract by Modulating the Nrf2/FPN1 Signaling Pathway. | FASEB J | 2025 | 41416389 | PubTator, text mining | PubMed |
| FTO-Mediated Mitigation of Ferroptosis Occurs in an ACSL4-Dependent Manner in Diabetic Cardiomyopathy. | Cardiovasc Toxicol | 2025 | 41410720 | PubTator, text mining | PubMed |
| Ginkgetin reverses cisplatin resistance in cervical cancer by regulating the Nrf2/HO-1 signaling pathway to induce ferroptosis. | Sci Rep | 2025 | 41408403 | PubTator, text mining | PubMed |
| Triple-negative breast cancer and ferroptosis: expression profiling of key regulatory genes. | Arch Med Sci | 2025 | 41403634 | PubTator, text mining | PubMed |
| Traumatic brain injury-related ferroptosis: current perspectives. | J Mol Med (Berl) | 2025 | 41396556 | PubTator, text mining | PubMed |
| Recent advances in the interaction of ferroptosis and immune-mediated inflammation in cardiovascular disease: mechanisms and therapeutic potential. | Front Immunol | 2025 | 41394800 | PubTator, text mining | PubMed |
| HPDA-based tubule-targeting nanoplatform alleviates oxidative stress and ferroptosis for the reversal of renal interstitial fibrosis. | J Nanobiotechnology | 2025 | 41390419 | PubTator, text mining | PubMed |
| Targeting Ferroptosis in Nasopharyngeal Carcinoma: Mechanisms, Resistance, and Precision Therapeutic Opportunities. | Int J Mol Sci | 2025 | 41373599 | PubTator, text mining | PubMed |
| Therapeutic targeting SPI1 in combination with erastin promotes ferroptosis in ccRCC. | Commun Biol | 2025 | 41372608 | PubTator, text mining | PubMed |
| Senescence-Primed Ferroptosis Enabled by a Metal-Organic Framework Nanoplatform for Enhanced Cancer Therapy. | ACS Nano | 2025 | 41358603 | PubTator, text mining | PubMed |
| [Bioinformatics screening and analysis of key genes of ferroptosis and autophagy in alcoholic liver disease and their validation]. | Zhonghua Gan Zang Bing Za Zhi | 2025 | 41355132 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2182/papers?page=28